Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

"This is a very clear effort to shine a light on this anti-vaccine trope: that thimerosal is somehow dangerous.” ...

Moderna’s latest flu vaccine, based on similar mRNA technology integrated in its COVID-19 shot, displayed optimistic outcomes ...

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

A federal vaccine panel recently reshaped by US health secretary Robert F. Kennedy Jr., has voted to discourage the use of ...

CDC advisory committee recommends thimerosal-free influenza vaccines for all adults and children, despite claims that the ...